Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-25

Clinical Trial Update: Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports results for nivolumab in localized renal cell carcinoma patients undergoing nephrectomy, with the study currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPDIVO (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-04-25